Nephros, Inc.

(OTC: NEPH)

A reader of StocksHaven Investments by the name of Michael Sklar has contributed the following article regarding Nephros, Inc. The article outlines one of the most undervalued BioPharma companies around, at only $1.08 PPS with three pending FDA decisions. If you are an avid investor of pre-PDUFA companies, StocksHaven Investments highly suggests you conduct some due diligence on this company, as its potential value greatly outweighs the risks involved. About: Nephros, Inc. (Nephros) is engaged primarily in the development of hemodiafiltration (HDF), products and technologies for treating patients with end stage renal disease (ESRD). The Company has three products in various stages of development in the HDF modality to deliver therapy to ESRD patients: OLpur MDHDF filter series (which it sells in various countries in Europe and consists of its MD190 and MD220 diafilters);

Changing Times Vitamins, Inc. (SGTB.PK), headquartered in Scottsdale, Arizona, was pleased to announce yesterday that it has entered into an agreement with Coors of Las Vegas to distribute its primary product, RecoveryX.

As a leader in the wholesale distribution of beverages, Coors of Las Vegas is on a mission to continually improve sales and service to meet both its suppliers’ and customers’ expectations. Through its team of highly trained associates, Coors only sells premium and regional brands through its distribution network. 60 to 70 percent of Coors’ business is to hotels, casinos, and restaurants.

RecoveryX is a unique product that contains a patent pending, clinically-tested algae extract that has shown the ability to reduce swelling and inflammation. As most athletes are aware, swelling and inflammation often occur after an intense work-out and may last for several hours. Extended periods of swelling hamper an athlete’s ability for a quick recovery and

eFoodSafety.com (EFSF) is a developer of nutraceutical products to help improve an array of health conditions for consumers. Nutraceutical products are defined by their combination of natural foods and supplements and the market for such products is estimated to reach $845 billion by 2015.

eFoodSafety’s products focus on wellness issues including lowered cholesterol, boosted metabolism, acne prevention and scarring reduction. The company’s Cinnergen product, which is used to provide nutrients to metabolize blood sugar, is currently available in major retailers such as GNC, Rite Aid and Vitamin Shoppe.

The Arizona-based company’s Cinnechol product is used to naturally treat cholesterol problems and competes in a $20-billion market. eFoodSafety is also working on products to treat skin problems, including acne, and staph infections and viruses. The company’s popular Boost Bar is used by health-conscious consumers to boost their immune systems. In June, the company said its OraPhyt product, which is used